Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
immunology
Biotech
BMS inks $15B deal to bag Hengrui assets, tap China’s R&D speed
BMS formed a broad partnership with Hengrui, paying $600 million upfront to advance 13 early-stage programs from across the two companies’ pipelines.
Nick Paul Taylor
May 12, 2026 1:56am
Biogen inks $850M deal with TJ for China rights antibody
Apr 20, 2026 10:26am
Odyssey charts new voyage to Nasdaq after false start last year
Apr 20, 2026 7:19am
Boehringer, Amgen scrap immunology assets, citing low potential
Apr 14, 2026 4:00am
OrbiMed-backed Pinnacle adds $89M for oral peptides
Mar 26, 2026 10:29am
After $1B fundraise, Xaira breaks silence on AI work
Mar 17, 2026 2:52pm